EGFR inhibitor erlotinib plus monoclonal antibody versus erlotinib alone for first-line treatment of advanced non-small cell lung carcinoma: A systematic review and meta-analysis
Author:
Funder
Sichuan University
West China Hospital, Sichuan University
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference61 articles.
1. Cancer Statistics;Siegel;CA Cancer J Clin.,2022
2. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021;Ettinger;J Natl Compr Canc Netw.,2021
3. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer;Paz-Ares;J Clin Oncol.,2013
4. Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer;Hayashi;Ann Oncol.,2012
5. Cancer immunotherapy;McNutt;Science (New York, N.Y.),2013
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance;Frontiers in Immunology;2024-08-05
2. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non‐small cell lung cancer;Chemical Biology & Drug Design;2023-12-18
3. Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights;Bioorganic Chemistry;2023-11
4. Label-free analysis of membrane protein binding kinetics and cell adhesions using evanescent scattering microscopy;The Analyst;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3